Several studies show that ligand Wnt5a often activates the Wnt–Ca2+ pathway in cancer cells and higher expression of Wnt5a suppresses breast and colorectal cancer (CRC) [20,21]. This evidence concerns the gene WNT5A and colorectal carcinoma.